Rifabutin is active in murine models of toxoplasmosis.
Rifabutin, a semisynthetic derivative of rifamycin S, was examined alone and in combination with other drugs for activity in treatment of systemic toxoplasmosis and toxoplasmic encephalitis in murine models. One hundred percent of the mice infected with a lethal inoculum of tachyzoites or cysts of T...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284499/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203856/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.570 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|